Cyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q3 2018 Results - Earnings Call Transcript [Seeking Alpha]
Cyclacel Pharmaceuticals, Inc. (CYCC)
Last cyclacel pharmaceuticals, inc. earnings: 2/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.cyclacel.com/investor-relations
Company Research
Source: Seeking Alpha
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC ) Q3 2018 Results Earnings Conference Call November 12, 2018 4:30 PM ET Executives Alexander Fudukidis - Investor Relations, Vice President at Russo Partners, LLC Spiro Rombotis - President, Chief Executive Officer Paul McBarron - Executive Vice President of Finance, Chief Operating Officer, Secretary Judy Chiao - Vice President of Clinical Development and Regulatory Affairs Analysts Jotin Marango - ROTH Capital Wangzhi Li - Ladenburg Thalmann Operator Good afternoon and welcome to the Cyclacel Pharmaceuticals' Third Quarter 2018 Results Conference Call and Webcast. Today's call is being recorded. At this time, all participants have been placed in a listen-only mode and the floor will be open for your questions following the presentation. [Operator Instructions] The company will also be accepting a limited number of questions submitted via e-mail to the address ir@cyclacel.com. It is now my pleasure to turn th
Show less
Read more
Impact Snapshot
Event Time:
CYCC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CYCC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CYCC alerts
High impacting Cyclacel Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
CYCC
News
- MiMedx Group, Cyclacel Pharmaceuticals, Predictive Oncology among healthcare movers [Seeking Alpha]Seeking Alpha
- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Is Expected To Breakeven In The Near Future [Yahoo! Finance]Yahoo! Finance
- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Cyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for CancerGlobeNewswire
CYCC
Earnings
- 3/19/24 - Beat
CYCC
Sec Filings
- 4/25/24 - Form S-1/A
- 4/19/24 - Form S-1/A
- 3/28/24 - Form 8-K
- CYCC's page on the SEC website